Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); an existing header style for Intervention/Treatment was updated, while the old Revision: v3.5.5 was removed and Revision: v3.6.0 was added.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page now displays a new Revision: v3.5.5 tag, replacing Revision: v3.5.4, indicating a minor internal update to the site's versioning rather than a change to study details.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small platform update and does not alter the study details or how users interact with the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a different release/version of the website interface rather than a change to the clinical trial details.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.